By Healthcare Practice Leaders | April 16, 2018

Medicare Advantage: The Future Model of Care

The current administration is pushing to grow privatized Medicare through Medicare Advantage plans in an effort to curb healthcare spending. As these plans continue to grow in popularity among patients, hospitals and health systems will have to adapt to the new environment by shifting to value-based care.


By Healthcare Practice Leaders | March 13, 2018

Tax Reform: What Repeal of ACA Individual Mandate Means & More

What does tax reform mean for healthcare organizations? It depends on whether you’re a for-profit or non-profit entity. We explain in this post.


By Healthcare Practice Leaders | March 06, 2018

Healthcare’s 5-year Cyber Outlook: Predictions with AHA

U.S. healthcare organizations saw nearly 290 large-scale data breaches (those impacting 500 or more individuals) last year. Here are some of our predictions for cybersecurity in healthcare over the next five years, as told in our article in Futurescan 2018-2023: Healthcare...


By Healthcare Practice Leaders | February 26, 2018

BDO’s 2018 Life Sciences Outlook

BDO’s Life Sciences practice makes four predictions for the industry in 2018, including that mainstream milestone-based reimbursements and a biotech M&A recovery are coming.


By Healthcare Practice Leaders | February 12, 2018

3 Foundational Shifts in Healthcare

Three foundational shifts are behind major healthcare developments: mandates to choice, regulation to competition, and subsidies to actuarial soundness. Here’s what they mean for healthcare’s stakeholders.


By Healthcare Practice Leaders | February 05, 2018

Infographic: Looking Back at 2017 PE Healthcare Buyouts

The number of completed U.S. healthcare deals involving a private equity buyer or seller was down in 2017 compared to the previous year, but deal value saw an increase. BDO’s PErspective in Healthcare infographic has more.


By Healthcare Practice Leaders | January 29, 2018

What Life Sciences Companies Need to Know About Tax Reform

To help organizations navigate the issues most impactful and urgent to the life sciences industry, we’ve prepared a summary of the industry implications based on the signed legislation.